Onconic Therapeutics KRX:476060KOSDAQ

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

1. 1
   Onconicotherapeutics water-free Jacubo breaks into India and targets China

   1 outlets · 2 articlesFirst report Nov 6 08:01 이데일리
2. 2
   Onconicotherapeutics' Jacubo expected to gain Chinese approval within year

   1 outlets · 1 articlesFirst report Nov 10 07:00 메디코파마
3. 3
   Onconicotherapeutics' Jacubo maintains acid suppression after meals: academic journal

   1 outlets · 1 articlesFirst report Nov 6 10:22 PRESS9
4. 4
   Onconicotherapeutics' Jacubo monthly prescription amount surpasses 10 billion won

   1 outlets · 1 articlesFirst report Nov 10 09:30 브릿지경제

• Nov 1009:30
  Onconicotherapeutics' Jacubo monthly prescription amount surpasses 10 billion won

  브릿지경제
• Nov 1007:00
  Onconicotherapeutics' Jacubo expected to gain Chinese approval within year

  메디코파마
• Nov 610:22
  Onconicotherapeutics' Jacubo maintains acid suppression after meals: academic journal

  PRESS9
• Nov 608:02
  Onconicotherapeutics water-free Jacubo breaks into India and targets China

  이데일리

  1 more on this story · 1 outlets

  • Onconicotherapeutics water-free Jacubo breaks into India and targets China이데일리 · Nov 6 08:01
• Oct 2714:41
  MajorOnconicotherapeutics' Jacubo orally disintegrating tablet bioavailability published in international journal

  바이오타임즈New technology
• Oct 2708:49
  Onconicotherapeutics to earn with Jacubo and grow new cancer and obesity drugs

  서울경제
• Oct 2314:52
  Onconicotherapeutics' Jacubo orally disintegrating tablet confirms bioequivalence

  글로벌경제신문
• Oct 2311:38
  Good morning! Pharm-bio news on the 23rd: Daewoong Pharmaceutical, Onconicotherapeutics, Dongwha Pharm, Meditoxin, CJ Biopharma

  굿모닝경제Dongwha PharmDaewoong PharmaMedy-Tox

  1 more on this story · 1 outlets

  • Pharma and biotech briefing: Daewoo Pharmaceutical, Meditoxs, Donghwa Pharmaceutical비즈니스플러스 · Oct 23 16:04
• Oct 2309:53
  Water-free P-CAB formulation: OncoNic Therapeutics' Jacubo orally disintegrating tablet equivalence research published in SCI-tier journal

  더페어뉴스
• Oct 2309:18
  OncoNic Therapeutics: Jacubo shows equivalent drug exposure even without water

  히트뉴스
• Oct 2309:13
  MajorOncoNic Therapeutics' Jacubo orally disintegrating tablet bioequivalence study published in international journal PR&P

  소셜밸류New technology

  1 more on this story · 1 outlets

  • OncoNic Therapeutics: Jacubo orally disintegrating tablet research published in journal전자신문 · Oct 23 15:31
• Oct 2309:09
  OncoNic Therapeutics' Jacubo orally disintegrating tablet shows equivalence to existing tablet even without water

  PRESS9
• Oct 2309:08
  Weekly today: Industrial news_JW Lee Jong-ho Foundation, OncoNic Therapeutics (10.23)

  위클리오늘
• Oct 2308:54
  OncoNic Therapeutics: Jacubo orally disintegrating tablet confirms equivalent drug exposure to existing tablet

  이투데이

  1 more on this story · 1 outlets

  • OncoNic Therapeutics' Jacubo orally disintegrating tablet confirms equivalent drug exposure to existing tabletCNB뉴스 · Oct 23 15:54
• Oct 2308:44
  OncoNic Therapeutics' Jacubo orally disintegrating tablet demonstrates bioequivalence with existing tablet, published in SCI-tier journal

  파이낸셜투데이

  5 more on this story · 5 outlets

  • OncoNic Therapeutics' Jacubo orally disintegrating tablet confirms bioequivalence with existing tablet메디컬투데이 · Oct 23 09:01
  • OncoNic Therapeutics: Jacubo orally disintegrating tablet confirms bioequivalence with existing tabletCatchNews · Oct 23 09:37
  • OncoNic Therapeutics' Jacubo orally disintegrating tablet published in UK SCI-tier journal, establishes bioequivalence녹색경제신문 · Oct 23 09:45
  • OncoNic Therapeutics' Jacubo orally disintegrating tablet bioequivalence study published in international journal더트래커 · Oct 23 10:19
  • OncoNic Therapeutics' Jacubo orally disintegrating tablet confirms bioequivalence with existing tablet뉴데일리경제 · Oct 23 14:29
• Oct 2213:38
  OncoNic Therapeutics expands oncology and obesity drug development based on Jacubo revenue

  파이낸셜뉴스
• Oct 2211:29
  OncoNic Therapeutics develops new drug to address muscle loss from GLP-1 obesity treatment, enters combination therapy market

  더스탁
• Oct 2206:26
  MajorOncoNic Therapeutics' novel drug Jacubo dyslipidemia treatment combination study published in SCI-tier international journal

  비즈트리뷴New technology
• Oct 2121:46
  OncoNic Therapeutics confirms tolerability of Jacubo with atorvastatin combination therapy

  팍스경제TV
• Oct 2112:40
  Weekly today: Industrial news_Daewoong Pharmaceutical, OncoNic Therapeutics (10.21)

  위클리오늘Dong-a ST
• Oct 2111:21
  OncoNic Therapeutics' Jacubo secures clinical evidence for dyslipidemia drug combination therapy

  뉴데일리경제
• Oct 2111:13
  MajorOncoNic Therapeutics' Jacubo dyslipidemia drug combination study published in SCI-tier international journal

  CNB뉴스New technology

  1 more on this story · 1 outlets

  • OncoNic Therapeutics releases Jacubo dyslipidemia drug interaction research findings포인트데일리 · Oct 21 17:36
• Oct 2109:46
  MajorOncoNic Therapeutics' Jacubo validates combination safety, published in international journal

  전자신문New technology

  1 more on this story · 1 outlets

  • OncoNic Therapeutics publishes Jacubo-atorvastatin combination research in SCI-tier international journal DDDT더스탁 · Oct 21 20:05
• Oct 2109:32
  OncoNic Therapeutics' Jacubo shows no change in drug exposure when combined with dyslipidemia treatment

  메디컬투데이
• Oct 2109:26
  OncoNic Therapeutics: Jacubo shows minimal drug-drug interaction with dyslipidemia treatment

  머니투데이
• Oct 2109:18
  OncoNic Therapeutics' Jacubo secures evidence for dyslipidemia drug combination

  파이낸셜뉴스

  6 more on this story · 6 outlets

  • OncoNic Therapeutics' Jacubo establishes clinical evidence for dyslipidemia treatment combination한국경제 · Oct 21 09:26
  • OncoNic Therapeutics' Jacubo secures evidence for dyslipidemia treatment combination데일리한국 · Oct 21 09:31
  • OncoNic Therapeutics' Jacubo published in SCI-tier international journal, secures atorvastatin combination safety evidence녹색경제신문 · Oct 21 10:51
  • OncoNic Therapeutics' Jacubo establishes clinical evidence for dyslipidemia treatment combination therapy백세시대 · Oct 21 13:58
  • OncoNic Therapeutics' Jacubo establishes clinical evidence for dyslipidemia treatment combination아이뉴스24 · Oct 21 14:56
  • OncoNic Therapeutics' Jacubo secures evidence for dyslipidemia treatment combination브릿지경제 · Oct 21 16:43
• Oct 2109:17
  OncoNic Therapeutics: confirms safety of Jacubo and dyslipidemia drug combination

  CatchNews
• Oct 1306:11
  OncoNic Therapeutics unveils obesity treatment combination drug at American Obesity Society

  비즈트리뷴
• Oct 1217:38
  OncoNic Therapeutics researches drug candidate for obesity treatment combination therapy

  지디넷코리아
• Oct 1216:14
  OncoNic Therapeutics focuses on skeletal muscle preservation with obesity combination drug

  CatchNews